A citation-based method for searching scientific literature

Suraj Saksena, Pratip Chattopadhyay. Cytometry B Clin Cytom 2021
Times Cited: 7







List of co-cited articles
18 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A dynamic COVID-19 immune signature includes associations with poor prognosis.
Adam G Laing, Anna Lorenc, Irene Del Molino Del Barrio, Abhishek Das, Matthew Fish, Leticia Monin, Miguel Muñoz-Ruiz, Duncan R McKenzie, Thomas S Hayday, Isaac Francos-Quijorna,[...]. Nat Med 2020
325
28

[Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV].
Y D Peng, K Meng, H Q Guan, L Leng, R R Zhu, B Y Wang, M A He, L X Cheng, K Huang, Q T Zeng. Zhonghua Xin Xue Guan Bing Za Zhi 2020
254
28



Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
Chaolin Huang, Yeming Wang, Xingwang Li, Lili Ren, Jianping Zhao, Yi Hu, Li Zhang, Guohui Fan, Jiuyang Xu, Xiaoying Gu,[...]. Lancet 2020
28

[A pathological report of three COVID-19 cases by minimal invasive autopsies].
X H Yao, T Y Li, Z C He, Y F Ping, H W Liu, S C Yu, H M Mou, L H Wang, H R Zhang, W J Fu,[...]. Zhonghua Bing Li Xue Za Zhi 2020
534
28

Clinical characteristics of 82 cases of death from COVID-19.
Bicheng Zhang, Xiaoyang Zhou, Yanru Qiu, Yuxiao Song, Fan Feng, Jia Feng, Qibin Song, Qingzhu Jia, Jun Wang. PLoS One 2020
187
28

Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China.
Chuan Qin, Luoqi Zhou, Ziwei Hu, Shuoqi Zhang, Sheng Yang, Yu Tao, Cuihong Xie, Ke Ma, Ke Shang, Wei Wang,[...]. Clin Infect Dis 2020
28

Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019.
Juanjuan Zhao, Quan Yuan, Haiyan Wang, Wei Liu, Xuejiao Liao, Yingying Su, Xin Wang, Jing Yuan, Tingdong Li, Jinxiu Li,[...]. Clin Infect Dis 2020
28

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.
Roujian Lu, Xiang Zhao, Juan Li, Peihua Niu, Bo Yang, Honglong Wu, Wenling Wang, Hao Song, Baoying Huang, Na Zhu,[...]. Lancet 2020
28

Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure.
Evangelos J Giamarellos-Bourboulis, Mihai G Netea, Nikoletta Rovina, Karolina Akinosoglou, Anastasia Antoniadou, Nikolaos Antonakos, Georgia Damoraki, Theologia Gkavogianni, Maria-Evangelia Adami, Paraskevi Katsaounou,[...]. Cell Host Microbe 2020
907
28

High-sensitivity flow cytometric assays: Considerations for design control and analytical validation for identification of Rare events.
Ulrike Sommer, Steven Eck, Laura Marszalek, Jennifer J Stewart, Jolene Bradford, Thomas W McCloskey, Cherie Green, Alessandra Vitaliti, Teri Oldaker, Virginia Litwin. Cytometry B Clin Cytom 2021
12
28

Flow cytometric method transfer: Recommendations for best practice.
Maciej Cabanski, Teri Oldaker, Jennifer J Stewart, Nithianandan Selliah, Steve Eck, Cherie Green, Virginia Litwin, Alessandra Vitaliti. Cytometry B Clin Cytom 2021
5
40

Best practices for optimization and validation of flow cytometry-based receptor occupancy assays.
Ed Hilt, Yongliang S Sun, Thomas W McCloskey, Steve Eck, Thomas McIntosh, Katharine D Grugan, David F Lanham, Nathan Standifer, Cherie Green, Virginia Litwin,[...]. Cytometry B Clin Cytom 2021
3
66

New cytometry tools for immune monitoring during cancer immunotherapy.
Shomyseh Sanjabi, Sean Lear. Cytometry B Clin Cytom 2021
3
66

Best practices for the development, analytical validation and clinical implementation of flow cytometric methods for chimeric antigen receptor T cell analyses.
Ghanashyam Sarikonda, Mélissa Mathieu, Mahwish Natalia, Anil Pahuja, Qiong Xue, Piotr L Pierog, Paul C Trampont, Vilma Decman, Susan Reynolds, Laïla-Aïcha Hanafi,[...]. Cytometry B Clin Cytom 2021
7
28

Recommendations for the validation of flow cytometric testing during drug development: II assays.
Denise M O'Hara, Yuanxin Xu, Zhiyan Liang, Manjula P Reddy, Dianna Y Wu, Virginia Litwin. J Immunol Methods 2011
71
28

A flow cytometric assay for HLA-DR expression on monocytes validated as a biomarker for enrollment in sepsis clinical trials.
Karen J Quadrini, Lisa Patti-Diaz, Jasmin Maghsoudlou, Joanne Cuomo, Michael Nathan Hedrick, Thomas W McCloskey. Cytometry B Clin Cytom 2021
4
50

Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE study.
Amit Bar-Or, Jonathan C Calkwood, Cathy Chognot, Joanna Evershed, Edward J Fox, Ann Herman, Marianna Manfrini, John McNamara, Derrick S Robertson, Daniela Stokmaier,[...]. Neurology 2020
122
14

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.
Stephen L Hauser, Emmanuelle Waubant, Douglas L Arnold, Timothy Vollmer, Jack Antel, Robert J Fox, Amit Bar-Or, Michael Panzara, Neena Sarkar, Sunil Agarwal,[...]. N Engl J Med 2008
14

Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial.
Alasdair J Coles, Cary L Twyman, Douglas L Arnold, Jeffrey A Cohen, Christian Confavreux, Edward J Fox, Hans-Peter Hartung, Eva Havrdova, Krzysztof W Selmaj, Howard L Weiner,[...]. Lancet 2012
732
14

Pulsed immune reconstitution therapy in multiple sclerosis.
Per Soelberg Sorensen, Finn Sellebjerg. Ther Adv Neurol Disord 2019
29
14

The COVID-19 pandemic and the use of MS disease-modifying therapies.
Gavin Giovannoni, Chris Hawkes, Jeannette Lechner-Scott, Michael Levy, Emmanuelle Waubant, Julian Gold. Mult Scler Relat Disord 2020
112
14

Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19.
Lauren B Rodda, Jason Netland, Laila Shehata, Kurt B Pruner, Peter A Morawski, Christopher D Thouvenel, Kennidy K Takehara, Julie Eggenberger, Emily A Hemann, Hayley R Waterman,[...]. Cell 2021
232
14

Dominant extrafollicular B cell responses in severe COVID-19 disease correlate with robust viral-specific antibody production but poor clinical outcomes.
Matthew Woodruff, Richard Ramonell, Kevin Cashman, Doan Nguyen, Ankur Saini, Natalie Haddad, Ariel Ley, Shuya Kyu, J Christina Howell, Tugba Ozturk,[...]. medRxiv 2020
29
14

Long-term peripheral immune cell profiling reveals further targets of oral cladribine in MS.
Tobias Moser, Kerstin Schwenker, Michael Seiberl, Julia Feige, Katja Akgün, Elisabeth Haschke-Becher, Tjalf Ziemssen, Johann Sellner. Ann Clin Transl Neurol 2020
12
14

EAN consensus statement for management of patients with neurological diseases during the COVID-19 pandemic.
T J von Oertzen, A Macerollo, M A Leone, E Beghi, M Crean, S Oztuk, C Bassetti, A Twardzik, D Bereczki, G Di Liberto,[...]. Eur J Neurol 2021
16
14



Comprehensive mapping of immune perturbations associated with severe COVID-19.
Leticia Kuri-Cervantes, M Betina Pampena, Wenzhao Meng, Aaron M Rosenfeld, Caroline A G Ittner, Ariel R Weisman, Roseline S Agyekum, Divij Mathew, Amy E Baxter, Laura A Vella,[...]. Sci Immunol 2020
298
14

Alemtuzumab in Multiple Sclerosis: Mechanism of Action and Beyond.
Tobias Ruck, Stefan Bittner, Heinz Wiendl, Sven G Meuth. Int J Mol Sci 2015
100
14

Ocrelizumab Depletes CD20⁺ T Cells in Multiple Sclerosis Patients.
Stefan Gingele, Thais Langer Jacobus, Franz Felix Konen, Martin W Hümmert, Kurt-Wolfram Sühs, Philipp Schwenkenbecher, Jonas Ahlbrecht, Nora Möhn, Lars H Müschen, Lena Bönig,[...]. Cells 2018
45
14

The structural basis of accelerated host cell entry by SARS-CoV-2†.
Murat Seyran, Kazuo Takayama, Vladimir N Uversky, Kenneth Lundstrom, Giorgio Palù, Samendra P Sherchan, Diksha Attrish, Nima Rezaei, Alaa A A Aljabali, Shinjini Ghosh,[...]. FEBS J 2021
60
14

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
Stephen L Hauser, Amit Bar-Or, Giancarlo Comi, Gavin Giovannoni, Hans-Peter Hartung, Bernhard Hemmer, Fred Lublin, Xavier Montalban, Kottil W Rammohan, Krzysztof Selmaj,[...]. N Engl J Med 2017
697
14

COVID-19: An Immunopathologic Assault.
Nancy Munro, Kristine Anne Scordo, Misty M Richmond. AACN Adv Crit Care 2020
1
100

Primary prevention of COVID-19: Advocacy for vaccination from a neurological perspective.
Johann Sellner, Thomas M Jenkins, Tim J von Oertzen, Claudio L Bassetti, Ettore Beghi, Daniel Bereczki, Benedetta Bodini, Francesco Cavallieri, Giovanni Di Liberto, Raimund Helbok,[...]. Eur J Neurol 2021
5
20

Safety and efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study.
Gavin Giovannoni, Per Soelberg Sorensen, Stuart Cook, Kottil Rammohan, Peter Rieckmann, Giancarlo Comi, Fernando Dangond, Abidemi K Adeniji, Patrick Vermersch. Mult Scler 2018
112
14

Multiple Sclerosis Disease-Modifying Therapy and the COVID-19 Pandemic: Implications on the Risk of Infection and Future Vaccination.
Crystal Zheng, Indrani Kar, Claire Kaori Chen, Crystal Sau, Sophia Woodson, Alessandro Serra, Hesham Abboud. CNS Drugs 2020
37
14


Patients with chronic lymphocytic leukemia with high-risk genomic features have inferior outcome on successive Cancer and Leukemia Group B trials with alemtuzumab consolidation: subgroup analysis from CALGB 19901 and CALGB 10101.
Jeffrey A Jones, Amy S Ruppert, Weiqiang Zhao, Thomas S Lin, Kanti Rai, Bercedis Peterson, Richard A Larson, Guido Marcucci, Nyla A Heerema, John C Byrd. Leuk Lymphoma 2013
5
20

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
Fernando P Polack, Stephen J Thomas, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, John L Perez, Gonzalo Pérez Marc, Edson D Moreira, Cristiano Zerbini,[...]. N Engl J Med 2020
14

Alemtuzumab treatment alters circulating innate immune cells in multiple sclerosis.
Catharina C Gross, Diana Ahmetspahic, Tobias Ruck, Andreas Schulte-Mecklenbeck, Kathrin Schwarte, Silke Jörgens, Stefanie Scheu, Susanne Windhagen, Bettina Graefe, Nico Melzer,[...]. Neurol Neuroimmunol Neuroinflamm 2016
56
14

Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity.
Carolyn Rydyznski Moderbacher, Sydney I Ramirez, Jennifer M Dan, Alba Grifoni, Kathryn M Hastie, Daniela Weiskopf, Simon Belanger, Robert K Abbott, Christina Kim, Jinyong Choi,[...]. Cell 2020
456
14

Features of Human CD3+CD20+ T Cells.
Elisabeth Schuh, Kerstin Berer, Matthias Mulazzani, Katharina Feil, Ingrid Meinl, Harald Lahm, Markus Krane, Rüdiger Lange, Kristina Pfannes, Marion Subklewe,[...]. J Immunol 2016
80
14


Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis.
Céline Louapre, Nicolas Collongues, Bruno Stankoff, Claire Giannesini, Caroline Papeix, Caroline Bensa, Romain Deschamps, Alain Créange, Abir Wahab, Jean Pelletier,[...]. JAMA Neurol 2020
195
14

Levels of expression of CD52 in normal and leukemic B and T cells: correlation with in vivo therapeutic responses to Campath-1H.
L Ginaldi, M De Martinis, E Matutes, N Farahat, R Morilla, M J Dyer, D Catovsky. Leuk Res 1998
208
14

RNA Vaccines for COVID-19: 5 Things Every Cardiologist Should Know.
Chien-Jung Lin, Robert P Mecham, Douglas L Mann. JACC Basic Transl Sci 2020
3
33

Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial.
Ludwig Kappos, David Li, Peter A Calabresi, Paul O'Connor, Amit Bar-Or, Frederik Barkhof, Ming Yin, David Leppert, Robert Glanzman, Jeroen Tinbergen,[...]. Lancet 2011
446
14

Vaccination in Multiple Sclerosis: Friend or Foe?
Tobias Zrzavy, Herwig Kollaritsch, Paulus S Rommer, Nina Boxberger, Micha Loebermann, Isabella Wimmer, Alexander Winkelmann, Uwe K Zettl. Front Immunol 2019
30
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.